OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
Agnes Shanley is senior editor of Pharmaceutical Technology.
Branching out from roots in industrial biotechnology, Riffyn Data Systems (and its CEO Tim Gardner) is taking the message of data-driven process improvement to biopharma.
Determining the root cause of out-of-specification (OOS) and other problems requires a careful, deductive approach and a clear understanding of processes.
Better understanding and control of cell behavior is yielding benefits, upstream and beyond.
Core functions and those funded by fiscal year 2018 user fees are continuing, and 59% of the agency’s staffers are being retained.